<?xml version="1.0" encoding="UTF-8"?>
<p>According to the summary on compassionate use of RDV, this drug is formulated in two pharmaceutical forms (a solution—5 mg/mL and a lyophilized formulation—100 mg RDV powder) and is recommended to be administered intravenously (30–120 min) after reconstitution in 0.9% saline or 5% glucose solutions, with the therapeutic dosage being as follows: 200 mg on day 1 and 100 mg/day for the following 9 days. The recommended formulation of RDV for compassionate use is the lyophilized powder that must be reconstituted prior to use and administered intravenously, as stated above [
 <xref rid="B73-jcm-09-02084" ref-type="bibr">73</xref>,
 <xref rid="B79-jcm-09-02084" ref-type="bibr">79</xref>].
</p>
